Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deoxycytidylate deaminase is a zinc-dependent enzyme involved in pyrimidine metabolism, specifically catalyzing the hydrolytic deamination of deoxycytidine-5'-monophosphate (dCMP) to deoxyuridine-5'-monophosphate (dUMP), which is an essential precursor for thymidylate synthase and DNA synthesis. It is a homohexamer allosterically regulated by dCTP (activator) and dTTP (inhibitor), modulating its activity to maintain balanced nucleotide pools for DNA replication and repair. The enzyme is predominantly found in rapidly dividing cells and has structural similarities with cytidine deaminase, possessing a conserved zinc-binding motif essential for its catalytic function. Its significance in cell proliferation and DNA synthesis makes it relevant as a potential therapeutic target, particularly in cancer chemotherapy where enzymes of nucleotide metabolism are frequently inhibited.
Drugs may inhibit or modulate dCMP deaminase to affect DNA synthesis or induce cytotoxicity in rapidly dividing cells (anticancer mechanism) Anti-metabolite drugs block pyrimidine synthesis via deamination modulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxycytidylate deaminase (dCMP deaminase).